A
ETNB

AJOVista’s 89bio ETNB Stock Holding History

AJOVista’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,789
Closed -$42.3K – 188
2023
Q4 		$42.3K Buy
+3,789
New +$34.8K 0.05% 309

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

AJOVista's ETNB Position: Q1 2024 in Review

AJOVista sold out of 89bio (ETNB) in Q1 2024, closing a stake of 3,789 shares — an estimated $42.3K sold.

AJOVista first reported a position in ETNB in Q4 2023 and held it in 1 quarter. The position peaked at $42.3K in Q4 2023. 150 funds tracked by Wall St. Rank hold ETNB as of Q1 2024.

  • AJOVista reported no remaining 89bio position as of Q1 2024 after selling out during the quarter.
  • AJOVista sold 3,789 89bio shares in Q1 2024, an estimated $42.3K.
  • AJOVista first reported a position in 89bio in Q4 2023 and held it in 1 quarter.
  • AJOVista's 89bio position peaked at $42.3K in Q4 2023.
  • 150 funds tracked by Wall St. Rank held 89bio as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.